CHL1 gene polymorphisms increase lung cancer susceptibility

Wen Tian; Xuelian Li; Yangwu Ren; Zhihua Yin; Xiaowei Quan; Chang Zheng; Baosen Zhou

doi:10.18632/oncotarget.24057

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

CHL1 gene polymorphisms increase lung cancer susceptibility

Wen Tian _, Xuelian Li, Yangwu Ren, Zhihua Yin, Xiaowei Quan, Chang Zheng and Baosen Zhou

PDF | HTML | How to cite

Oncotarget. 2018; 9:13545-13550. https://doi.org/10.18632/oncotarget.24057

Metrics: PDF 1973 views | HTML 2367 views | ?

Abstract

Wen Tian1,2, Xuelian Li1,2, Yangwu Ren1,2, Zhihua Yin1,2, Xiaowei Quan1,2, Chang Zheng1,2 and Baosen Zhou1,2

1Department of Epidemiology, School of Public Health, China Medical University, Shenyang, China

2Key Laboratory of Cancer Etiology and Prevention, China Medical University, Liaoning Provincial Department of Education, Liaoning, Shenyang, China

Correspondence to:

Baosen Zhou, email: [email protected]

Keywords: polymorphism; lung cancer; susceptibility; CHL1

Received: September 30, 2017 Accepted: November 16, 2017 Published: January 06, 2018

ABSTRACT

Lung cancer represents a complex and malignant cancer. Close Homologue of L1 (CHL1) gene plays a crucial role in the progress of cancer. The aim of this study is to explore the association between CHL1 rs425366 polymorphism and lung cancer susceptibility in northeast of China. A hospital-based case-control study was carried out to collect relative characteristics. Logistic regression analysis was conducted to analyze the relationship between single nucleotide polymorphisms and lung cancer susceptibility. The results suggested that there was statistically significant difference between GT genotype and TT genotype of rs425366 and lung cancer susceptibility. In stratified analysis, TT genotype of rs425366 may increase the risk of lung adenocarcinoma. We also found that non-smoking individuals carrying T allele were more likely to develop lung cancer. Overall, our study may indicate that CHL1 gene may increase lung cancer susceptibility in northeast of China.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 24057

Publication Alerts

Post-Publication Promotion

Publication Discount

Research Papers:

CHL1 gene polymorphisms increase lung cancer susceptibility

Abstract